Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
3.070
+0.230 (8.10%)
May 14, 2026, 3:03 PM EDT - Market open
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $44.7 million as of May 14, 2026. Its market cap has increased by 74.60% in one year.
Market Cap
44.70M
Enterprise Value
19.29M
1-Year Change
74.60%
Ranking
Category
Stock Price
$3.07
Market Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $44.70M, a decrease of -54.39%. That is a compound annual growth rate of -6.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 38.30M | 38.77% |
| Dec 31, 2025 | 27.60M | 1.85% |
| Dec 31, 2024 | 27.10M | -11.15% |
| Dec 29, 2023 | 30.50M | -56.68% |
| Dec 30, 2022 | 70.40M | -54.05% |
| Dec 31, 2021 | 153.20M | 200.98% |
| Dec 31, 2020 | 50.90M | 271.53% |
| Dec 31, 2019 | 13.70M | 69.14% |
| Dec 31, 2018 | 8.10M | -38.17% |
| Dec 29, 2017 | 13.10M | -32.47% |
| Dec 30, 2016 | 19.40M | -74.67% |
| Dec 31, 2015 | 76.60M | -38.82% |
| Dec 31, 2014 | 125.20M | 27.76% |
| Apr 10, 2014 | 98.00M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mereo BioPharma Group | 41.50M |
| Aligos Therapeutics | 40.72M |
| Plus Therapeutics | 40.28M |
| Actinium Pharmaceuticals | 40.19M |
| RenovoRx | 38.93M |
| INmune Bio | 38.55M |
| Palatin Technologies | 38.00M |
| Tvardi Therapeutics | 37.62M |